×
For best experience we recommend to activate Javascript in your browser.
Recombinant CD3, CD20 (Odronextamab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-CD3, CD20 (Odronextamab Biosimilar) antibody has been validated for ELISA and WB. It is suitable to detect CD3, CD20 (Odronextamab Biosimilar) in samples from Human.
Catalog No. ABIN7488244
$336.06
Plus shipping costs $50.00
1 mg ABIN7470468
100 μg ABIN7488244
1 mg ABIN7470468
100 μg ABIN7488244
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant CD3, CD20 (Odronextamab Biosimilar) antibody (ABIN7488244)
Target
CD3, CD20 (Odronextamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
Product Details anti-CD3, CD20 (Odronextamab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Odronextamab Biosimilar - Anti-CD3, CD20 mAb
Characteristics
Antibody Type: IgG4-kappa
Purification
Recombinant antibody expressed in mammalien cells and purified.
Isotype
IgG4
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Buffer
PBS buffer pH 7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target Details for CD3, CD20 (Odronextamab Biosimilar)
(hide)
Target
CD3, CD20 (Odronextamab Biosimilar)
Sub Type
Cocktail
Target Type
Biosimilar
Background
REGN-1979
Recently viewed
(hide)
Chat with us , powered by LiveChat